Skip to main content
Year archive

Verona Pharma plc — 2018 filings

All 81 regulatory filings released by Verona Pharma plc (VRNA) in 2018, sourced directly from the official regulator.

81 Filings
2018 Period
2018 filings (81)
Filing Released Lang
Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD
Regulatory Filings
2018-12-17 English
Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD
Regulatory Filings
2018-12-17 English
Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD
Regulatory Filings
2018-12-17 English
Verona Pharma Initiates Phase 2 Clinical Trial to Evaluate Dry Powder Inhaler Formulation of RPL554 for Maintenance Treatment of COPD
Regulatory Filings
2018-12-17 English
6-K
Foreign Filer Report
2018-11-06 English
Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2018
Earnings Release 9M 2018
2018-11-06 English
Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2018
Earnings Release 9M 2018
2018-11-06 English
Verona Pharma Completes Enrollment in Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment
Regulatory Filings
2018-10-31 English
Verona Pharma to Announce Interim Results for Nine Months Ended September 30, 2018 and Provide Clinical Development Update
Report Publication Announcement
2018-10-30 English
Data from Clinical and Pre-Clinical Trials Evaluating Verona Pharma’s RPL554 in Cystic Fibrosis Presented at North American Cystic Fibrosis Conference
Regulatory Filings
2018-10-26 English
Verona Pharma to Host Investor & Analyst R&D Forum on October 12, 2018
Investor Presentation
2018-09-27 English
Verona Pharma to Host Investor & Analyst R&D Forum on October 12, 2018
Regulatory Filings
2018-09-27 English
6-K
Foreign Filer Report
2018-09-25 English
Issue of Shares & PDMR Announcement
Share Issue/Capital Change
2018-09-20 English
Issue of Shares & PDMR Announcement
Share Issue/Capital Change
2018-09-20 English
6-K
Foreign Filer Report
2018-08-14 English
6-K
Foreign Filer Report
2018-08-07 English
Verona Pharma Initiates Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment
Regulatory Filings
2018-08-01 English
Verona Pharma Initiates Phase 2 Clinical Trial Evaluating Nebulized RPL554 as Add-on to Dual Bronchodilator Therapy for COPD Maintenance Treatment
Regulatory Filings
2018-08-01 English
Verona Pharma plc : Notice of Results
Report Publication Announcement
2018-07-26 English
Verona Pharma plc : Notice of Results
Report Publication Announcement
2018-07-26 English
Verona Pharma to Present at 2018 Wedbush PacGrow Healthcare Conference
Regulatory Filings
2018-07-24 English
Verona Pharma to Present at 2018 Wedbush PacGrow Healthcare Conference
Regulatory Filings
2018-07-24 English
6-K EGM NOTICE
Foreign Filer Report
2018-06-28 English
Verona Pharma plc : Result of General Meeting of Shareholders
Declaration of Voting Results & Voting Rights Announcements
2018-06-26 English
Verona Pharma plc : Result of General Meeting of Shareholders
Declaration of Voting Results & Voting Rights Announcements
2018-06-26 English
Regulatory Filings 2018
Regulatory Filings
2018-06-05 English
6-K
Foreign Filer Report
2018-06-04 English
Verona Pharma's Shelf Registration Statement declared effective by SEC
Regulatory Filings
2018-06-04 English
Verona Pharma's Shelf Registration Statement declared effective by SEC
Regulatory Filings
2018-06-04 English
Verona Pharma plc : Block Listing Update
Share Issue/Capital Change
2018-05-31 English
Verona Pharma plc : Block Listing Update
Share Issue/Capital Change
2018-05-31 English
Regulatory Filings 2018
Regulatory Filings
2018-05-30 English
Verona Pharma to Present at Upcoming Investor Conferences
Investor Presentation
2018-05-30 English
Verona Pharma to Present at Upcoming Investor Conferences
Investor Presentation
2018-05-30 English
Regulatory Filings 2018
Regulatory Filings
2018-05-29 English
Verona Pharma Files Shelf Registration Statement with SEC
Capital/Financing Update
2018-05-23 English
Verona Pharma Files Shelf Registration Statement with SEC
Capital/Financing Update
2018-05-23 English
F-3
Regulatory Filings
2018-05-22 English
Verona Pharma Presented Clinical Data at ATS 2018 that Further Highlights RPL554 as a First-in-Class Treatment for COPD
Regulatory Filings
2018-05-22 English
Verona Pharma Presented Clinical Data at ATS 2018 that Further Highlights RPL554 as a First-in-Class Treatment for COPD
Regulatory Filings
2018-05-22 English
Verona Pharma plc : Miscellaneous
Regulatory Filings
2018-05-09 English
Verona Pharma plc : Miscellaneous
Regulatory Filings
2018-05-09 English
6-K
Foreign Filer Report
2018-05-08 English
Verona Pharma plc Operational Update and Financial Results for the First Quarter Ended March 31, 2018
Earnings Release Q1 2018
2018-05-08 English
Verona Pharma plc Operational Update and Financial Results for the First Quarter Ended March 31, 2018
Earnings Release Q1 2018
2018-05-08 English
6-K
Foreign Filer Report
2018-05-04 English
6-K
Foreign Filer Report
2018-05-04 English
Verona Pharma to Present at Bio€quity Europe 2018
Regulatory Filings
2018-05-04 English
Verona Pharma to Present at Bio€quity Europe 2018
Regulatory Filings
2018-05-04 English
Verona Pharma plc : Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2018-05-03 English
Verona Pharma plc : Result of AGM
Declaration of Voting Results & Voting Rights Announcements
2018-05-03 English
Verona Pharma to Announce Operational Update and Financial Results for First Quarter Ended March 31, 2018
Report Publication Announcement
2018-05-02 English
Verona Pharma to Announce Operational Update and Financial Results for First Quarter Ended March 31, 2018
Report Publication Announcement
2018-05-02 English
6-K
Foreign Filer Report
2018-04-18 English
Verona Pharma Announces Departure of Chief Medical Officer
Board/Management Information
2018-04-11 English
Verona Pharma Announces Departure of Chief Medical Officer
Board/Management Information
2018-04-11 English
6-K
Foreign Filer Report
2018-03-29 English
Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD
Earnings Release Q1 2018
2018-03-26 English
Verona Pharma Reports Positive Top-Line Data from Phase 2b Clinical Trial of RPL554 for Maintenance Treatment of COPD
Earnings Release Q1 2018
2018-03-26 English
6-K
Foreign Filer Report
2018-03-22 English
Verona Pharma to Present at Upcoming Healthcare Investor Conferences
Investor Presentation
2018-03-15 English
Verona Pharma to Present at Upcoming Healthcare Investor Conferences
Investor Presentation
2018-03-15 English
Verona Pharma plc: 2017 Annual Report and Accounts and Notice of AGM
Report Publication Announcement
2018-03-09 English
Verona Pharma plc: 2017 Annual Report and Accounts and Notice of AGM
Report Publication Announcement
2018-03-09 English
Verona Pharma plc : Grant of Options and RSUs and PDMR Dealings
Director's Dealing
2018-03-09 English
Verona Pharma plc : Grant of Options and RSUs and PDMR Dealings
Director's Dealing
2018-03-09 English
Verona Pharma plc : 1st Quarter Results
Director's Dealing
2018-03-08 English
Verona Pharma plc : 1st Quarter Results
Director's Dealing
2018-03-08 English
Second Price Monitoring Extn
Regulatory Filings
2018-03-02 English
Price Monitoring Extension
Regulatory Filings
2018-03-02 English
Verona Pharma Reports Positive Top-Line Data from Phase 2a Trial with RPL554 in Cystic Fibrosis Patients
Earnings Release Q1 2018
2018-03-02 English
Verona Pharma Reports Positive Top-Line Data from Phase 2a Trial with RPL554 in Cystic Fibrosis Patients
Regulatory Filings
2018-03-02 English
20-F
Annual Report FY 2017
2018-02-27 English
Verona Pharma plc ("Verona Pharma" or the "Company") Reports Operational Update and Financial Results for Full Year Ended December 31, 2017
Report Publication Announcement
2018-02-27 English
Verona Pharma plc ("Verona Pharma" or the "Company") Reports Operational Update and Financial Results for Full Year Ended December 31, 2017
Audit Report / Information FY 2017
2018-02-27 English
SC 13G/A
Major Shareholding Notification
2018-02-13 English
Verona Pharma Provides Clinical Development Update
Earnings Release Q1 2018
2018-02-13 English
Verona Pharma Provides Clinical Development Update
Earnings Release Q1 2018
2018-02-13 English
SC 13G/A
Major Shareholding Notification
2018-02-06 English
AMENDMENT NO. 1
Major Shareholding Notification
2018-01-26 English